ATX inhibitor 17

ATX inhibitor 17 is a potent ATX inhibitor with an IC50 of 0.019 μM. ATX inhibitor 17 shows excellent anti-proliferative activities in breast cancer cells[1].

Product Specifications

CAS Number

[2750152-64-6]

UNSPSC

12352005

Target

Phosphodiesterase (PDE)

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/atx-inhibitor-17.html

Solubility

10 mM in DMSO

Smiles

CC1=C(C2=CC(N3CCN(CC3)CCN(C)C)=C(C=C2N1)F)/C(C(F)(F)F)=N/NC4=NC(C5=CC=C(C=C5)F)=C(S4)C#N

Molecular Formula

C29H29F5N8S

Molecular Weight

616.65

References & Citations

[1]Lei H, et al. Structure guided design of potent indole-based ATX inhibitors bearing hydrazone moiety with tumor suppression effects. Eur J Med Chem. 2020 Sep 1;201:112456.